Clinical Trials

This study has been completed

Inclusion Criteria     

• Age 18–30 years
• Smoked an average of greater than or equal to 1 or more cigarettes per day during the past 6 months
• Binge drank on an average of  > 1 occasions per month during the past 3 months
  • Binge drinking is defined as consumption of > 5 standardized alcoholic drinks in a row for males or > 4  drinks in a row for females
• Able to participate fully in all aspects of the intervention and keep all scheduled appointments
• Willing to participate in 6 months of follow-up
• Willing to stop smoking and use nicotine patch therapy
• Willing to refrain from participating in additional smoking interventions for the duration of the study
• Provide written informed consent.

Exclusion Criteria:      

• Current (past 90 days) alcohol dependence as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders, Alcohol Dependence Module
• Current (past 12 months) non-nicotine or alcohol drug dependence as assessed by a Drug Abuse Screening Test-20 score of > 6
• Current elevation of depressive symptoms (past 2 weeks) that would be indicative of clinical depression as assessed by a Beck Depression Inventory-II score of > 20
• Current use (past 30 days) of nicotine containing medication or frequent use (> 10 occasions per month) of tobacco products other than cigarettes
• Current use (past 30 days) of any other smoking cessation treatment involving behavioral or pharmacological interventions
• Any medical condition that would preclude use of the nicotine patch including
  • current unstable angina
  • recent history (past 30 days) of myocardial infarction or stroke
  • history of severe skin allergies
  • evidence of severe chronic dermatosis
• Currently pregnant or breast feeding, or likely to become pregnant during the nicotine patch phase
• A member of the household has participated in the trial